{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T01:28:40Z","timestamp":1789176520989,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001824","name":"Czech Science Foundation","doi-asserted-by":"crossref","award":["GA15-13732S"],"award-info":[{"award-number":["GA15-13732S"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Internal Grant Agency of Palacky University","award":["LF_2016_014"],"award-info":[{"award-number":["LF_2016_014"]}]},{"DOI":"10.13039\/501100001823","name":"Ministry of Education, Youth and Sports","doi-asserted-by":"crossref","award":["LO1304"],"award-info":[{"award-number":["LO1304"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.bcmd.2017.04.003","type":"journal-article","created":{"date-parts":[[2017,4,14]],"date-time":"2017-04-14T09:50:05Z","timestamp":1492163405000},"page":"23-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Two novel mutations (p.(Ser160Pro) and p.(Arg472Cys)) causing glucose-6-phosphate isomerase deficiency are associated with erythroid dysplasia and inappropriately suppressed hepcidin"],"prefix":"10.1016","volume":"69","author":[{"given":"Renata","family":"Mojzikova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavla","family":"Koralkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dusan","family":"Holub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"Saxova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar","family":"Pospisilova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Prochazkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Dzubak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Horvathova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Divoky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2017.04.003_bb0005","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1053\/beha.1999.0059","article-title":"Glucose-6-phosphate isomerase deficiency","volume":"13","author":"Kugler","year":"2000","journal-title":"Baillieres Clin. Haematol."},{"key":"10.1016\/j.bcmd.2017.04.003_bb0010","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1006\/jmbi.2001.4680","article-title":"The crystal structure of human phosphoglucose isomerase at 1.6\u00b0A resolution: implications for catalytic mechanism, cytokine activity and haemolytic anaemia","volume":"309","author":"Read","year":"2001","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bcmd.2017.04.003_bb0015","series-title":"Hematology: Basic Principles and Practice","first-page":"611","article-title":"Red blood cells enzymopathies","author":"Gregg","year":"2009"},{"key":"10.1016\/j.bcmd.2017.04.003_bb0020","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/humu.9466","article-title":"Red cell glucose phosphate isomerase (GPI): a molecular study of three novel mutations associated with hereditary nonspherocytic hemolytic anemia","volume":"27","author":"Repiso","year":"2006","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bcmd.2017.04.003_bb0025","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.bbadis.2004.10.008","article-title":"Glucose phosphate isomerase deficiency: enzymatic and familial characterization of Arg346His mutation","volume":"1740","author":"Repiso","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bcmd.2017.04.003_bb0030","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S1079-9796(03)00027-5","article-title":"Combined glucose-6-phosphate dehydrogenase and glucosephosphate isomerase deficiency can alter clinical outcome","volume":"30","author":"Clarke","year":"2003","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2017.04.003_bb0035","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bcmd.2016.06.002","article-title":"Hereditary nonspherocytic hemolytic anemia caused by red cell glucose-6-phosphate isomerase (GPI) deficiency in two Portuguese patients: clinical features and molecular study","volume":"60","author":"Manco","year":"2016","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2017.04.003_bb0040","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1182\/blood.V32.2.236.236","article-title":"Hereditary hemolytic anemia associated with glucosephosphate isomerase (GPI) deficiency. A new enzyme defect of human erythrocytes","volume":"32","author":"Baugham","year":"1968","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2017.04.003_bb0045","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1056\/NEJM198701293160506","article-title":"Glucose phosphate isomerase deficiency as a cause of hydrops fetalis","volume":"316","author":"Ravindranath","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2017.04.003_bb0050","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/BF00441768","article-title":"Generalized glucose-phosphate isomerase (GPI) deficiency causing haemolytic anaemia, neuromuscular symptoms and impairment of granulocytic function: a new syndrome due to a new stable GPI variant with diminished specific activity (GPI Homburg)","volume":"144","author":"Schr\u00f6ter","year":"1985","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.bcmd.2017.04.003_bb0055","first-page":"21","article-title":"Clinical symptoms and biochemical properties of three new glucosephosphate isomerase variants","volume":"53","author":"Eber","year":"1986","journal-title":"Blutalkohol"},{"key":"10.1016\/j.bcmd.2017.04.003_bb0060","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s004390050849","article-title":"Molecular basis of neurological dysfunction coupled with haemolytic anaemia in human glucose-6-phosphate isomerase (GPI) deficiency","volume":"103","author":"Kugler","year":"1998","journal-title":"Hum. Genet."},{"key":"10.1016\/j.bcmd.2017.04.003_bb0065","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0167-4838(00)00075-3","article-title":"Phosphohexose isomerase\/autocrine motility factor\/neuroleukin\/maturation factor is a multifunctional phosphoprotein","volume":"1480","author":"Haga","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bcmd.2017.04.003_bb0070","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1006\/bbrc.2001.5135","article-title":"Tumor autocrine motility factor is an angiogenic factor that stimulates endothelial cell motility","volume":"285","author":"Funasaka","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcmd.2017.04.003_bb0075","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0014-5793(02)03072-7","article-title":"Species specificity of the cytokine function of phosphoglucose isomerase","volume":"525","author":"Amraei","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bcmd.2017.04.003_bb0080","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1159\/000205215","article-title":"Combination of congenital nonspherocytic haemolytic anaemia and impairment of granulocyte function in severe glucosephosphate isomerase deficiency. A new variant enzyme designated GPI Calden","volume":"83","author":"Neubauer","year":"1990","journal-title":"Acta Haematol."},{"key":"10.1016\/j.bcmd.2017.04.003_bb0085","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-2141.1971.tb07036.x","article-title":"Combined glucosephosphate isomerase and glucose-6-phosphate dehydrogenase deficiency of the erythrocytes: a new hemolytic syndrome","volume":"20","author":"Schr\u00f6ter","year":"1971","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2017.04.003_bb0090","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/BF00282031","article-title":"Combined erythrocyte glucosephosphate isomerase (GPI) and glucose-6-phosphate dehydrogenase (G6PD) deficiency in an Italian family","volume":"57","author":"Arnold","year":"1981","journal-title":"Hum. Genet."},{"key":"10.1016\/j.bcmd.2017.04.003_bb0095","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1182\/blood.V81.1.206.206","article-title":"Glucose-6-phosphate isomerase associated with nonsherocytic hemolytic anemia in the mouse: an animal model for the human disease","volume":"81","author":"Merkle","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2017.04.003_bb0100","unstructured":"W.W. Solinge, R. van Wijk. Erythrocyte enzyme disorders. In: Williams Hematology (Eds. K. Kaushansky, M.A. Lichtman, J.T. Prchal, M.M. Levi, O.W. Press, L.J. Burns, M. Caligiuri). 9th edition. McGraw-Hill Education. New York. 2016, pp. 689\u2013724."},{"key":"10.1016\/j.bcmd.2017.04.003_bb0105","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1146\/annurev-med-050109-142444","article-title":"Hepcidin and disorders of iron metabolism","volume":"62","author":"Ganz","year":"2011","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.bcmd.2017.04.003_bb0110","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1749-6632.2010.05585.x","article-title":"Hepcidin in beta-thalassemia","volume":"1202","author":"Nemeth","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bcmd.2017.04.003_bb0115","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/ejh.12027","article-title":"High levels of soluble serum hemojuvelin in patients with congenital dyserythropoietic anemia type, I","volume":"90","author":"Shalev","year":"2013","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.bcmd.2017.04.003_bb0120","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/bjh.12779","article-title":"Iron status in patients with pyruvate kinase deficiency: neonatal hyperferritinaemia associated with a novel frameshift deletion in the PKLR gene (p.Arg518fs), and low hepcidin to ferritin ratios","volume":"165","author":"Mojzikova","year":"2014","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2017.04.003_bb0125","doi-asserted-by":"crossref","first-page":"231","DOI":"10.5507\/bp.2015.054","article-title":"Characterization of iron metabolism and erythropoiesis in erythrocyte membrane defects and thalassemia traits","volume":"160","author":"Sulovska","year":"2016","journal-title":"Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub."},{"key":"10.1016\/j.bcmd.2017.04.003_bb0130","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.3324\/haematol.2014.104034","article-title":"Hepcidin levels in Diamond-Blackfan anemia reflect erythropoietic activity and transfusion dependency","volume":"99","author":"Pospisilova","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2017.04.003_bb0135","doi-asserted-by":"crossref","first-page":"667","DOI":"10.33549\/physiolres.930841","article-title":"Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis","volume":"55","author":"Vokurka","year":"2006","journal-title":"Physiol. Res."},{"key":"10.1016\/j.bcmd.2017.04.003_bb0140","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1182\/blood-2006-06-028787","article-title":"Suppression of hepcidin during anemia requires erythropoietic activity","volume":"108","author":"Pak","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2017.04.003_bb0145","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1182\/blood.V88.6.2306.bloodjournal8862306","article-title":"Study of the molecular defects in glucose phosphate isomerase-deficient patients affected by chronic hemolytic anemia","volume":"88","author":"Baronciani","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2017.04.003_bb0150","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2141.1977.tb00589.x","article-title":"International committee for standardization in haematology: recommended methods for red-cell enzyme analysis","volume":"35","author":"Beutler","year":"1977","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2017.04.003_bb0155","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.bcmd.2014.08.006","article-title":"Growth differentiation factor 15 expression and regulation during erythroid differentiation in non-transfusion dependent thalassemia","volume":"54","author":"Ronzoni","year":"2015","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2017.04.003_bb0160","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/ejh.12464","article-title":"Altered erythropoiesis and iron metabolism in carriers of thalassemia","volume":"94","author":"Guimar\u00e3es","year":"2015","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.bcmd.2017.04.003_bb0165","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/bcmd.1997.0157","article-title":"Glucosephosphate isomerase (GPI) deficiency mutations associated with hereditary nonspherocytic hemolytic anemia (HNSHA)","volume":"23","author":"Beutler","year":"1997","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2017.04.003_bb0170","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.bbapap.2008.11.004","article-title":"Effect of inherited mutations on catalytic activity and structural stability of human glucose-6-phosphate isomerase expressed in Escherichia coli","volume":"1794","author":"Lin","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bcmd.2017.04.003_bb0175","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1006\/bcmd.2001.0433","article-title":"Iron status and HFE genotype in erythrocyte pyruvate kinase deficiency: study of Italian cases","volume":"27","author":"Zanella","year":"2001","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2017.04.003_bb0180","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/ng.2996","article-title":"Identification of erythroferrone as an erythroid regulator of iron metabolism","volume":"46","author":"Kautz","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bcmd.2017.04.003_bb0185","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1182\/blood-2015-07-658419","article-title":"Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of \u03b2-thalassemia","volume":"126","author":"Kautz","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2017.04.003_bb0190","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1182\/blood.V128.22.1272.1272","article-title":"A novel dual monoclonal sandwich ELISA for Human Erythroferrone","volume":"128","author":"Han","year":"2016","journal-title":"Blood"}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979617300529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979617300529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:33:42Z","timestamp":1761050022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979617300529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":38,"alternative-id":["S1079979617300529"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2017.04.003","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Two novel mutations (p.(Ser160Pro) and p.(Arg472Cys)) causing glucose-6-phosphate isomerase deficiency are associated with erythroid dysplasia and inappropriately suppressed hepcidin","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2017.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}